Fund HoldingsArtia Global Partners LP

Total Portfolio Value
$389.85M
Total Bought
$164.77M
Total Sold
$145.80M
Net Transaction
+$18.97M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
ELI LILLY & CO(LLY)(Put)075,000+75,000067,904+67,904
NOVO-NORDISK A S(Put)0310,000+310,000044,249+44,249
ELI LILLY & CO(LLY)92,59392,593072,03483,83221.50%+11,798
NOVO-NORDISK A S(NVO)691,743691,743088,82098,73925.33%+9,920
ALNYLAM PHARMACEUTICALS INC(ALNY)035,000+35,00008,5052.18%+8,505
VIKING THERAPEUTICS INC(VKTX)(Call)0150,000+150,00007,952+7,952
INSMED INC(INSM)(Put)0110,000+110,00007,370+7,370
MERCK & CO INC(MRK)379,200442,504+63,30450,03554,78214.05%+4,747
IONIS PHARMACEUTICALS INC(IONS)062,479+62,47902,9780.76%+2,978
CELLDEX THERAPEUTICS INC NEW(CLDX)075,300+75,30002,7870.71%+2,787
SOLENO THERAPEUTICS INC40,92494,424+53,5001,7523,8520.99%+2,101
ASTRAZENECA PLC(AZN)190,752190,752012,92314,8773.82%+1,953
SYNDAX PHARMACEUTICALS INC(SNDX)048,263+48,26309910.25%+991
KEROS THERAPEUTICS INC020,000+20,00009140.23%+914
CORBUS PHARMACEUTICALS HLDGS020,000+20,00009050.23%+905
DYNE THERAPEUTICS INC(DYN)119,488119,48803,3924,2171.08%+824
PROTAGONIST THERAPEUTICS INC124,440124,44003,6004,3121.11%+712
MERUS N V50,17150,17102,2592,9690.76%+709
VAXCYTE INC(PCVX)76,25576,25505,2095,7581.48%+549
SAREPTA THERAPEUTICS INC(SRPT)02,600+2,60004110.11%+411
INSMED INC(INSM)118,23653,436-64,8003,2083,5800.92%+372
KURA ONCOLOGY INC(KURA)39,47857,178+17,7008421,1770.30%+335
INTRA-CELLULAR THERAPIES INC210,096216,519+6,42314,53914,8293.80%+291
LARIMAR THERAPEUTICS INC58,19090,490+32,3004426560.17%+214
MEREO BIOPHARMA GROUP PLC421,359421,35901,3901,5170.39%+126
AXSOME THERAPEUTICS INC(AXSM)87,84887,84807,0107,0721.81%+61
MADRIGAL PHARMACEUTICALS INC(MDGL)1,5571,55704164360.11%+20
NEUROCRINE BIOSCIENCES INC(NBIX)45,00045,00006,2066,1951.59%-11
SILENCE THERAPEUTICS PLC52,47652,47601,1339970.26%-136
XENON PHARMACEUTICALS INC(XENE)40,00040,00001,7221,5600.40%-162
CRINETICS PHARMACEUTICALS IN(CRNX)85,76585,76504,0153,8410.99%-173
EYEPOINT PHARMACEUTICALS INC(EYPT)51,500101,500+50,0001,0658830.23%-181
VERONA PHARMA PLC130,790130,79002,1041,8910.49%-213
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
54,28554,28501,2841,0430.27%-241
GRITSTONE BIO INC95,1700-95,1702450-245
POSEIDA THERAPEUTICS INC86,0020-86,0022740-274
ANNEXON INC(ANNX)147,485147,48501,0577230.19%-335
EFFECTOR THERAPEUTICS INC(Call)25,0000-25,0003600-360
IDEAYA BIOSCIENCES INC(IDYA)52,49254,392+1,9002,3031,9100.49%-394
CHARLES RIV LABS INTL INC(CRL)6,9056,90501,8711,4260.37%-444
BIOMEA FUSION INC35,4520-35,4525300-530
SPRINGWORKS THERAPEUTICS INC53,93053,93002,6542,0320.52%-623
IMMUNOVANT INC(IMVT)21,3970-21,3976910-691
MACROGENICS INC64,0070-64,0079420-942
PLIANT THERAPEUTICS INC100,00050,000-50,0001,4905380.14%-952
VERA THERAPEUTICS INC(VERA)24,2980-24,2981,0480-1,048
RAPT THERAPEUTICS INC137,3080-137,3081,2330-1,233
ASCENDIS PHARMA A/S(ASND)15,8947,440-8,4542,4031,0150.26%-1,388
ARVINAS INC40,0000-40,0001,6510-1,651
APOGEE THERAPEUTICS INC(APGE)61,59058,400-3,1904,0932,2980.59%-1,795
JANUX THERAPEUTICS INC(JANX)47,9490-47,9491,8050-1,805
ALPINE IMMUNE SCIENCES INC51,7140-51,7142,0500-2,050
OCULAR THERAPEUTIX INC(OCUL)724,685500,000-224,6856,5953,4200.88%-3,175
VERTEX PHARMACEUTICALS INC(VRTX)28,90018,900-10,00012,0808,8592.27%-3,222
DISC MEDICINE INC(IRON)87,04013,440-73,6005,4196060.16%-4,813
CYTOKINETICS INC(CYTK)89,5250-89,5256,2770-6,277
ARGENX SE(ARGX)34,23815,138-19,10013,4806,5101.67%-6,970
VIKING THERAPEUTICS INC(VKTX)433,580452,979+19,39935,55424,0126.16%-11,541
ABBVIE INC(ABBV)90,8210-90,82116,5390-16,539
ELI LILLY & CO(LLY)(Put)115,0000-115,00089,4650-89,465
Page 1 of 1